AvantGuard is a venture backed, Cornell University spin-off, IndieBio/SOSV alum with grant funding from the NIH and NSF, run by an experienced entrepreneur. Our proprietary complex gives skin an immune boost, destroys established biofilms and re-balances the microbiome to treat conditions like acne, eczema, and dandruff. We target the >$100 billion skincare/dermatology market with an early-revenue, capital-efficient, low-risk model.